Laura Kibuuka Selected Research

2- fluoro- 6- (tetrahydrofuran- 3- ylamino)- 4- (3,6,6- trimethyl- 4- oxo- 4,5,6,7- tetrahydro- 1H- indol- 1- yl)benzamide

1/2014

Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not α-synuclein-induced neuronal cell loss.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Kibuuka Research Topics

Disease

1	Weight Loss (Weight Reduction) 01/2014
1	Parkinsonian Disorders (Parkinsonism) 01/2014
1	Gliosis 05/2013
1	Parkinson Disease (Parkinson's Disease) 05/2013

Drug/Important Bio-Agent (IBA)

1	2- fluoro- 6- (tetrahydrofuran- 3- ylamino)- 4- (3,6,6- trimethyl- 4- oxo- 4,5,6,7- tetrahydro- 1H- indol- 1- yl)benzamideIBA 01/2014
1	Dopamine (Intropin)FDA LinkGeneric 01/2014
1	SynucleinsIBA 01/2014
1	alpha-SynucleinIBA 05/2013